GlobeImmune
(OTC) GBIM
GlobeImmune Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$6.21M
Net Income (TTM)
$2.07M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
68.63 (High)
Dividend
$0.00
Beta (Volatility)
68.63 (High)
Price
$0.00
Volume
190
Open
$0.00
Price
$0.00
Volume
190
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
68.63 (High)
Price
$0.00
Volume
190
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
GBIM News
GBIM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GlobeImmune
GBIM Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
-43%
Net Income Margin
-43%
Return on Equity
0%
Return on Capital
-38%
Return on Assets
-24%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
5.75M
Volume
190
Short Interest
0.00%
Avg. Volume
521.672
Financials (TTM)
Gross Profit
$3.81M
Operating Income
$2.77M
EBITDA
$2.58M
Operating Cash Flow
$7.13M
Capital Expenditure
$35.74K
Free Cash Flow
$7.17M
Cash & ST Invst.
$9.90M
Total Debt
$0.00
GlobeImmune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$942.75K
-20.6%
Gross Profit
$428.02K
+307.6%
Gross Margin
45.40%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
2
N/A
Net Income
$862.21K
+44.7%
EBITDA
$843.12K
+43.1%
Quarterly Fundamentals
Net Cash
$8.69M
-39.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-24.05%
N/A
Return on Invested Capital
-38.00%
N/A
Free Cash Flow
$1.21M
+50.8%
Operating Cash Flow
$1.21M
+50.4%